tenk.fyi

Estrella Immunopharma, Inc.

ESLANasdaq· Biological Products, (No Diagnostic Substances)

Price History

Revenue

-

Net Income

-$13.1M

195.1% YoY

EPS

$-0.35

191.7% YoY

Cash

$1.4M

51.0% YoY

FY 2025 · As of 2025-12-31

No recent insider transactions found.

ProShowing last 90 days. Full 12+ month history available on Pro.
Upgrade